Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PYGB | P11216 | 8/20 | 0.35 |
| ▸ | PYGL | P06737 | 3/20 | 0.35 |
| ▸ | PYGM | P11217 | 2/20 | 0.35 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.32 |
| ▸ | OGA | O60502 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17035735 | 1.00 | MEN1 (0.38) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL17035756 | 1.00 | MEN1 (0.38) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL19088712 | 1.00 | MEN1 (0.38) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL17035749 | 1.00 | MEN1 (0.38) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL8585884 | 0.94 | PYGB (0.41) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL5703493 | 0.94 | PYGB (0.41) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL28265605 | 0.94 | PYGB (0.41) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL16259329 | 0.94 | PYGB (0.41) | MEN1KMT2APYGBPYGLPYGM | |
| Alcohol SCHEMBL27584412 | 0.86 | MEN1 (0.47) | MEN1KMT2APYGBPYGLPYGM | |
| Alcohol SCHEMBL28858025 | 0.86 | MEN1 (0.47) | MEN1KMT2APYGBPYGLPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | STT3B, STT3A, DDOST | MEN1 2616/4885KMT2A 2780/4885PYGB 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.